Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Brain Behav Immun ; 50: 52-57, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26116982

ABSTRACT

BACKGROUND: Spaceflight is associated with immune dysregulation which is considered as risk factor for the performance of exploration-class missions. Among the consequences of confinement and other environmental factors of living in hostile environments, the role of different oxygen concentrations is of importance as either low (e.g. as considered for lunar or Martian habitats) or high (e.g. during extravehicular activities) can trigger immune dysfunction. The aim of this study was to investigate the impact of increased oxygen availability--generated through hyperbaricity--on innate immune functions in the course of a 14 days NEEMO mission. METHODS: 6 male subjects were included into a 14 days undersea deployment at the Aquarius station (Key Largo, FL, USA). The underwater habitat is located at an operating depth of 47 ft. The 2.5 times higher atmospheric pressure in the habitat leads to hyperoxia. The collection of biological samples occurred 6 days before (L-6), at day 7 (MD7) and 11/13 (MD11/13) during the mission, and 90 days thereafter (R). Blood analyses included differential blood cell count, ex vivo innate immune activation status and inhibitory competences of granulocytes. RESULTS: The absolute leukocyte count showed an increase during deployment as well as the granulocyte and monocyte count. Lymphocyte count was decreased on MD7. The assessments of native adhesion molecules on granulocytes (CD11b, CD62L) indicated a highly significant cellular activation (L-6 vs. MD7/MD13) during mission. In contrast, granulocytes were more sensitive towards anti-inflammatory stimuli (adenosine) on MD13. CONCLUSION: Living in the NEEMO habitat for 14 days induced significant immune alterations as seen by an activation of adhesion molecules and vice versa higher sensitivity towards inhibition. This investigation under hyperbaric hyperoxia is important especially for Astronauts' immune competence during extravehicular activities when exposed to similar conditions.


Subject(s)
Hyperoxia/immunology , Immunity, Innate , Inflammation/immunology , Cytokines/immunology , Humans , Hyperoxia/blood , Inflammation/metabolism , Integrin beta Chains/immunology , Integrin beta Chains/metabolism , Leukocytes/immunology , Male , Monocytes/immunology , Space Flight , United States , United States National Aeronautics and Space Administration
2.
Brain Behav Immun ; 41: 210-7, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24886968

ABSTRACT

Latent virus reactivation and diurnal salivary cortisol and dehydroepiandrosterone were measured prospectively in 17 astronauts (16 male and 1 female) before, during, and after short-duration (12-16 days) Space Shuttle missions. Blood, urine, and saliva samples were collected during each of these phases. Antiviral antibodies and viral load (DNA) were measured for Epstein-Barr virus (EBV), varicella-zoster virus (VZV), and cytomegalovirus (CMV). Three astronauts did not shed any virus in any of their samples collected before, during, or after flight. EBV was shed in the saliva in all of the remaining 14 astronauts during all 3 phases of flight. Seven of the 14 EBV-shedding subjects also shed VZV during and after the flight in their saliva samples, and 8 of 14 EBV-shedders also shed CMV in their urine samples before, during, and after flight. In 6 of 14 crewmembers, all 3 target viruses were shed during one or more flight phases. Both EBV and VZV DNA copies were elevated during the flight phase relative to preflight or post-flight levels. EBV DNA in peripheral blood was increased preflight relative to post-flight. Eighteen healthy controls were also included in the study. Approximately 2-5% of controls shed EBV while none shed VZV or CMV. Salivary cortisol measured preflight and during flight were elevated relative to post-flight. In contrast DHEA decreased during the flight phase relative to both preflight and post-flight. As a consequence, the molar ratio of the area under the diurnal curve of cortisol to DHEA with respect to ground (AUCg) increased significantly during flight. This ratio was unrelated to viral shedding. In summary, three herpes viruses can reactivate individually or in combination during spaceflight.


Subject(s)
Astronauts , Cytomegalovirus/physiology , Herpesviridae Infections/virology , Herpesvirus 3, Human/physiology , Herpesvirus 4, Human/physiology , Space Flight , Viremia/etiology , Virus Activation , Adult , Antibodies, Viral/blood , Circadian Rhythm , Cytomegalovirus/immunology , Cytomegalovirus/isolation & purification , DNA, Viral/blood , Female , Herpesviridae Infections/immunology , Herpesviridae Infections/metabolism , Herpesvirus 3, Human/immunology , Herpesvirus 3, Human/isolation & purification , Herpesvirus 4, Human/immunology , Herpesvirus 4, Human/isolation & purification , Humans , Hydrocortisone/metabolism , Infant, Newborn , Male , Middle Aged , Saliva/chemistry , Saliva/virology , Spacecraft , Stress, Physiological , Urine/virology , Viral Load , Viremia/virology , Virus Latency
3.
Cytokine ; 61(1): 205-9, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23107825

ABSTRACT

Success of long duration space missions will depend upon robust immunity. Decreased immunity has been observed in astronauts during short duration missions, as evident by the reactivation of latent herpes viruses. Seventeen astronauts were studied for reactivation and shedding of latent herpes viruses before, during, and after 9-14 days of 8 spaceflights. Blood, urine, and saliva samples were collected 10 days before the flight (L-10), during the flight (saliva only), 2-3h after landing (R+0), 3 days after landing (R+3), and 120 days after landing (R+120). Values at R+120 were used as baseline levels. No shedding of viruses occurred before flight, but 9 of the 17 (designated "virus shedders") shed at least one or more viruses during and after flight. The remaining 8 astronauts did not shed any of the 3 target viruses (non-virus shedders). Virus-shedders showed elevations in 10 plasma cytokines (IL-1α, IL-6, IL-8, IFNγ, IL-4, IL-10, IL-12, IL-13, eotaxin, and IP-10) at R+0 over baseline values. Only IL-4 and IP-10 were elevated in plasma of non-virus shedders. In virus shedders, plasma IL-4 (a Th2 cytokine) was elevated 21-fold at R+0, whereas IFNγ (a Th1 cytokine) was elevated only 2-fold indicating a Th2 shift. The inflammatory cytokine IL-6 was elevated 33-fold at R+0. In non-shedding astronauts at R+0, only IL-4 and IP-10 levels were elevated over baseline values. Elevated cytokines began returning to normal by R+3, and by R+120 all except IL-4 had returned to baseline values. These data show an association between elevated plasma cytokines and increased viral reactivation in astronauts.


Subject(s)
Cytokines/blood , Herpesviridae/physiology , Space Flight , Virus Activation , Virus Latency , Adult , Astronauts , Female , Humans , Male , Middle Aged , Saliva/virology , Stress, Physiological , Stress, Psychological , Th2 Cells/immunology , Th2 Cells/metabolism , Virus Shedding
4.
J Epidemiol Community Health ; 63(10): 792-8, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19282316

ABSTRACT

BACKGROUND: Substantial research has suggested that exposure to environmental health hazards, such as polluting industrial activity, has deleterious effects on psychological and physiological well-being. However, one gap in the existing literature is comparative analysis of objective and subjective exposure's relative association with various measurable outcomes of exposure. METHODS: These relationships were explored within a community sample of 2604 respondents living near a large petrochemical complex in Texas City, Texas, USA. Objective exposure was investigated using distance of residence from a cluster of petrochemical plants and subjective exposure using residents' concern about potential health effects from those plants. Regression models were then used to examine how each type of exposure predicts perceived stress, physiological markers of stress and perceived health. RESULTS: Results suggest that objective exposure was associated primarily with markers of physiological stress (interleukin-6 and viral reactivation), and subjective exposure (concern about petrochemical health risk) was associated with variables assessing perceived health. CONCLUSIONS: From the analysis, it can be inferred that, in the context of an environmental hazard of this type, subjective exposure may be at least as important a predictor of poor health outcomes as objective exposure.


Subject(s)
Chemical Industry , Environmental Pollution/adverse effects , Stress, Physiological/physiology , Stress, Psychological/psychology , Biomarkers/blood , Environmental Exposure/adverse effects , Female , Health Status Indicators , Humans , Interleukin-6/blood , Male , Middle Aged , Petroleum , Public Opinion , Risk Assessment , Texas/epidemiology , Virus Activation
5.
Cochrane Database Syst Rev ; (2): CD006564, 2008 Apr 16.
Article in English | MEDLINE | ID: mdl-18425954

ABSTRACT

BACKGROUND: Dopamine agonists are being used increasingly as first line treatment for Parkinson's disease, but there remains uncertainty about their clinical and cost-effectiveness relative to levodopa. OBJECTIVES: This meta-analysis aims to quantify more reliably the benefits and risks of dopamine agonists compared to placebo or levodopa in early Parkinson's disease. SEARCH STRATEGY: We searched CENTRAL (The Cochrane Library), MEDLINE, EMBASE, PubMed, LILACS and Web of Science, plus major journals in the field, abstract books, conference proceedings and reference lists of retrieved publications. SELECTION CRITERIA: Randomised trials comparing an orally administered dopamine agonist (with or without levodopa) versus placebo or levodopa or both placebo and levodopa in participants with early Parkinson's disease. DATA COLLECTION AND ANALYSIS: Two authors independently extracted data on clinician-rated disability, motor complications, other side-effects, treatment concordance, levodopa dose and mortality. MAIN RESULTS: Twenty-nine eligible trials, involving 5247 participants, were identified. Participants randomised to a dopamine agonist were less likely to develop dyskinesia (odds ratio (OR) 0.51, 95% confidence interval (CI) 0.43 to 0.59; P < 0.00001), dystonia (OR 0.64, 95% CI 0.51 to 0.81; P = 0.0002) and motor fluctuations (OR 0.75, 95% CI 0.63 to 0.90; P = 0.002) than levodopa-treated participants. However, various 'non-motor' side-effects, including oedema (OR 3.68, 95% CI 2.62 to 5.18; P < 0.00001), somnolence (OR 1.49, 95% CI 1.12 to 2.00; P = 0.007), constipation (OR 1.59, 95% CI 1.11 to 2.28; P = 0.01), dizziness (OR 1.45, 95% CI 1.09 to 1.92; P = 0.01), hallucinations (OR 1.69, 95% CI 1.13 to 2.52; P = 0.01) and nausea (OR 1.32, 95% CI 1.05 to 1.66; P = 0.02) were all increased in agonist-treated participants (compared with levodopa-treated participants). Agonist-treated participants were also significantly more likely to discontinue treatment due to adverse events (OR 2.49, 95% CI 2.08 to 2.98; P < 0.00001). Finally symptomatic control of Parkinson's disease was better with levodopa than with agonists, but data were reported too inconsistently and incompletely to meta-analyse. AUTHORS' CONCLUSIONS: This meta-analysis confirms that motor complications are reduced with dopamine agonists compared to levodopa, but also establishes that other important side-effects are increased and symptom control is poorer with agonists. Larger, long-term comparative trials assessing patient-rated quality of life are needed to assess more reliably the balance of benefits and risks of dopamine agonists compared to levodopa.


Subject(s)
Antiparkinson Agents/therapeutic use , Dopamine Agonists/therapeutic use , Parkinson Disease/drug therapy , Dyskinesia, Drug-Induced , Humans , Levodopa/therapeutic use , Randomized Controlled Trials as Topic
6.
Cochrane Database Syst Rev ; (3): CD004898, 2005 Jul 20.
Article in English | MEDLINE | ID: mdl-16034956

ABSTRACT

BACKGROUND: It has been postulated that monoamine oxidase B (MAO-B) inhibitors alter disease progression in Parkinson's disease (PD). Clinical trials have produced conflicting results. OBJECTIVES: To assess the evidence from randomized controlled trials for the effectiveness and safety of long-term use of MAO-B inhibitors in early PD. SEARCH STRATEGY: We searched the following electronic databases: Cochrane Central Register of Controlled trials (CENTRAL) (The Cochrane Library Issue 2, 2004), MEDLINE (last searched 18th August 2004) and EMBASE (last searched 18th August 2004). We also handsearched neurology and movement disorders conference proceedings, checked reference lists of relevant studies and contacted other researchers. SELECTION CRITERIA: We sought to include all unconfounded randomized controlled trials that compared a MAO-B inhibitor with control, in the presence or absence of levodopa or dopamine agonists, in patients with early PD and where treatment and follow up lasted at least one year. DATA COLLECTION AND ANALYSIS: Two reviewers independently selected trials for inclusion, assessed the methodological quality, and extracted the data. A small amount of additional data was provided by the original authors. Random-effects models were used to analyse results, where appropriate. MAIN RESULTS: Ten trials were included (a total of 2422 patients), nine using selegiline, one using lazabemide. The methodological quality was reasonable although concealment of allocation was definitely adequate in only four trials. The mean follow up was for 5.8 years. MAO-B inhibitors were not associated with a significant increase in deaths (odds ratio (OR) 1.15; 95% confidence interval (CI) 0.92 to 1.44). They provided small benefits over control in impairment (weighted mean difference (WMD) for change in motor UPDRS score was 3.81 points less with MAO-B inhibitors; 95% CI 2.27 to 5.36) and disability (WMD for change in UPDRS ADL score was 1.50 less; 95% CI 0.48 to 2.53) at one year which, although statistically significant, were not clinically significant. There was a marked levodopa-sparing effect with MAO-B inhibitors which was associated with a significant reduction in motor fluctuations (OR 0.75; 95% CI 0.59 to 0.94) but not dyskinesia (OR 0.97; 95% CI 0.76 to 1.25). The reduction in motor fluctuations was, however, not robust in sensitivity analyses. Although adverse events were generally mild and infrequent, withdrawals due to side-effects were higher (OR 2.36; 95% CI 1.32 to 4.20) with MAO-B inhibitors. AUTHORS' CONCLUSIONS: MAO-B inhibitors do not appear to delay disease progression but may have a beneficial effect on motor fluctuations. There was no statistically significant effect on deaths although the confidence interval does not exclude a small increase with MAO-B inhibitors. At present we do not feel these drugs can be recommended for routine use in the treatment of early Parkinson's disease but further randomized controlled trials should be carried out to clarify, in particular, their effect on deaths and motor complications.


Subject(s)
Monoamine Oxidase Inhibitors/therapeutic use , Parkinson Disease/drug therapy , Antiparkinson Agents/therapeutic use , Dopamine Agonists/therapeutic use , Humans , Levodopa/therapeutic use , Picolinic Acids/therapeutic use , Randomized Controlled Trials as Topic , Selegiline/therapeutic use
7.
Brain Behav Immun ; 19(3): 235-42, 2005 May.
Article in English | MEDLINE | ID: mdl-15797312

ABSTRACT

Patterns of Epstein-Barr virus (EBV) reactivation in 32 astronauts and 18 healthy age-matched control subjects were characterized by quantifying EBV shedding. Saliva samples were collected from astronauts before, during, and after 10 space shuttle missions of 5-14 days duration. At one time point or another, EBV was detected in saliva from each of the astronauts. Of 1398 saliva specimens from 32 astronauts, polymerase chain reaction analysis showed that 314 (23%) were positive for EBV DNA. Examination by flight phase showed that 29% of the saliva specimens collected from 28 astronauts before flight were positive for EBV DNA, as were 16% of those collected from 25 astronauts during flight and 16% of those collected after flight from 23 astronauts. The mean number of EBV copies from samples taken during the flights was 417 per mL, significantly greater (p<.05) than the number of viral copies from the preflight (40) and postflight (44) phases. In contrast, the control subjects shed EBV DNA with a frequency of 3.7% and mean number of EBV copies of 40 per mL of saliva. Ten days before flight and on landing day, titers of antibody to EBV viral capsid antigen were significantly (p<.05) greater than baseline levels. On landing day, urinary levels of cortisol and catecholamines were greater than their preflight values. In a limited study (n=5), plasma levels of substance P and other neuropeptides were also greater on landing day. Increases in the number of viral copies and in the amount of EBV-specific antibody were consistent with EBV reactivation before, during, and after space flight.


Subject(s)
Astronauts , Herpesvirus 4, Human/isolation & purification , Saliva/virology , Space Flight , Stress, Physiological/virology , Virus Shedding/physiology , Adult , Antibodies/blood , Antibodies/immunology , Antigens, Viral/immunology , Capsid Proteins/immunology , Catecholamines/urine , DNA, Viral/analysis , Female , Herpesvirus 4, Human/immunology , Humans , Hydrocortisone/urine , Male , Middle Aged , Neuropeptides/blood , Stress, Physiological/immunology , Stress, Physiological/metabolism , Virus Shedding/immunology
9.
J Neurol Neurosurg Psychiatry ; 74(4): 519-21, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12640080

ABSTRACT

There has been a striking resurgence of interest in surgery for Parkinson's disease (PD) with new targets identified and new procedures developed. This systematic review identified over 500 studies of surgery for PD published since 1990, including over 10 000 patients. However, the authors were unable to assess the value of PD surgery reliably because only seven randomised trials were identified including just 196 patients. Studies of surgery for PD have generally been of poor quality with too few patients, too short follow up, inappropriate choice of outcome measures, and lack of control groups. Much larger, randomised, controlled trials are needed to assess the longer term effects of surgery on patient rated quality of life and cost effectiveness.


Subject(s)
Clinical Trials as Topic/statistics & numerical data , Evidence-Based Medicine/statistics & numerical data , Parkinson Disease/surgery , Reproducibility of Results , Stereotaxic Techniques/statistics & numerical data , Humans , Outcome Assessment, Health Care/statistics & numerical data
10.
Psychosom Med ; 63(6): 891-5, 2001.
Article in English | MEDLINE | ID: mdl-11719627

ABSTRACT

OBJECTIVE: The objective of this study was to determine the effects of stress and spaceflight on levels of neuroendocrine hormones and Epstein-Barr virus (EBV)-specific antibodies in astronauts. METHODS: Antiviral antibody titers and stress hormones were measured in plasma samples collected from 28 astronauts at their annual medical exam (baseline), 10 days before launch (L-10), landing day (R+0), and 3 days after landing (R+3). Urinary stress hormones were also measured at L-10 and R+0. RESULTS: Significant increases (p <.01) in EBV virus capsid antigen antibodies were found at all three time points (L-10, R+0, and R+3) as compared with baseline samples. Anti-EBV nuclear antigen antibodies were significantly decreased at L-10 (p <.05) and continued to decrease after spaceflight (R+0 and R+3, p <.01). No changes were found in antibodies to the nonlatent measles virus. The 11 astronauts who showed evidence of EBV reactivation had significant increases in urinary epinephrine and norepinephrine as compared with astronauts without EBV reactivation. CONCLUSION: These findings indicate that physical and psychological stresses associated with spaceflight resulted in decreased virus-specific T-cell immunity and reactivation of EBV.


Subject(s)
Epstein-Barr Virus Infections/virology , Herpesvirus 4, Human/growth & development , Hydrocortisone/metabolism , Space Flight , Stress, Psychological/immunology , Stress, Psychological/metabolism , Virus Activation , Adult , Antibodies, Viral/immunology , Epstein-Barr Virus Infections/immunology , Female , Humans , Immunoglobulin G/immunology , Male , Microscopy, Fluorescence , Middle Aged , Weightlessness
11.
Aviat Space Environ Med ; 72(10): 884-91, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11601551

ABSTRACT

BACKGROUND: Increased frequency and severity of herpesvirus infections are common in individuals with impaired cellular immunity, a phenomenon observed in both the elderly and astronauts alike. This study investigated immune responses and latent herpesvirus reactivation during a 9-d spaceflight. In addition, adrenocortical and immune responses of an elderly astronaut (payload specialist-2, PS2; age 77) who flew on this mission were compared with that of younger crewmembers. HYPOTHESIS: Spaceflight and associated stresses will decrease cellular immunity and reactivate latent herpesviruses. METHODS: Blood and urine samples, collected from the seven crewmembers who flew on the Space Shuttle Discovery (STS-95), were analyzed for levels of neuroendocrine hormones, leukocyte and lymphocyte subsets, and evidence of herpes-virus reactivation. RESULTS: Prior to flight, increased antibody titers to latent Epstein-Barr virus were found. During flight, acute changes in dehydroepiandrosterone sulfate (DHEAS) and cortisol resulted in a pronounced decrease in the DHEAS/cortisol ratio by the end of the mission for PS2 and a younger crewmember. Shedding of cytomegalovirus (CMV) in urine and increased CMV antibody titers also occurred inflight. At landing, the percent increases in adrenocorticotropic hormone and cortisol were greatest for PS2 as compared with the other six crewmembers. A significant neutrophilia also was observed in all crewmembers. Notably, PS2 had large increases in monocytes and natural killer cells at landing while other crewmembers showed little change or a decrease. CONCLUSIONS: These findings indicate that spaceflight and associated stresses reactivate latent herpesviruses and suggest that acute changes in neuroendocrine hormones mediate these changes in part by downregulating cellular immunity. Moreover, the similarities between aging and spaceflight suggest that the study of the immune system in elderly subjects may be useful as a predictive model for astronauts enduring long-term spaceflights.


Subject(s)
Astronauts , Herpesviridae/isolation & purification , Space Flight , Virus Activation/physiology , Virus Latency/physiology , Adult , Age Factors , Aged , Antibodies, Viral/analysis , Cytomegalovirus/immunology , Down-Regulation , Herpesviridae/immunology , Humans , Hydrocortisone/blood , Immunity, Cellular , Lymphocyte Subsets , Middle Aged , Stress, Psychological/immunology , Virus Shedding/physiology
12.
J Immunol Methods ; 247(1-2): 35-47, 2001 Jan 01.
Article in English | MEDLINE | ID: mdl-11150535

ABSTRACT

The ability to detect cytomegalovirus-specific T-cells (CD4(+)) in the peripheral blood by flow cytometry has been recently described by Picker et al. In this method, cells are incubated with viral antigen and responding (cytokine producing) T-cells are then identified by flow cytometry. To date, this technique has not been reliably used to detect Epstein-Barr virus (EBV)-specific T-cells primarily due to the superantigen/mitogenic properties of the virus which non-specifically activate T-cells. By modifying culture conditions under which the antigens are presented, we have overcome this limitation and developed an assay to detect and quantitate EBV-specific T-cells. The detection of cytokine producing T-cells by flow cytometry requires an extremely strong signal (such as culture in the presence of PMA and ionomycin). Our data indicate that in modified culture conditions (early removal of viral antigen) the non-specific activation of T-cells by EBV is reduced, but antigen presentation will continue uninhibited. Using this method, EBV-specific T-cells may be legitimately detected using flow cytometry. No reduction in the numbers of antigen-specific T-cells was observed by the early removal of target antigen when verified using cytomegalovirus antigen (a virus with no non-specific T-cell activation properties). In EBV-seropositive individuals, the phenotype of the EBV-specific cytokine producing T-cells was evaluated using four-color flow cytometry and found to be CD45(+), CD3(+), CD4(+), CD45RA(-), CD69(+), CD25(-). This phenotype indicates the stimulation of circulating previously unactivated memory T-cells. No cytokine production was observed in CD4(+) T-cells from EBV-seronegative individuals, confirming the specificity of this assay. In addition, the use of four color cytometry (CD45, CD3, CD69, IFNgamma/IL-2) allows the total quantitative assessment of EBV-specific T-cells while monitoring the interference of EBV non-specific mitogenic activity. This method may have significant utility for the monitoring of the immune response to latent virus infection/reactivation.


Subject(s)
Cell Separation/methods , Flow Cytometry/methods , Herpesvirus 4, Human/immunology , T-Lymphocytes/immunology , Adult , Antigens, CD/analysis , Antigens, Differentiation, T-Lymphocyte/analysis , Cells, Cultured , Child , Humans , Immunophenotyping , Interferon-gamma/analysis , Interleukin-2/analysis , Lectins, C-Type , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/virology , Lymphocyte Activation/immunology , Mitogens/immunology , Superantigens/immunology , T-Lymphocytes/cytology , T-Lymphocytes/virology
13.
J Infect Dis ; 182(6): 1761-4, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11069250

ABSTRACT

The reactivation of cytomegalovirus (CMV) in 71 astronauts was investigated, using polymerase chain reaction. A significantly greater (P<.0001) shedding frequency was found in urine samples from astronauts before spaceflight (10.6%) than in urine from the healthy control subject group (1.2%). Two of 4 astronauts studied during spaceflight shed CMV in urine. A significant increase (P<.0001) in CMV antibody titer, compared with baseline values, was also found 10 days before spaceflight. CMV antibody titer was further increased (P<.001) 3 days after landing, compared with 10 days before the mission. Significant increases in stress hormones were also found after landing. These results demonstrate that CMV reactivation occurred in astronauts before spaceflight and indicate that CMV may further reactivate during spaceflight.


Subject(s)
Antibodies, Viral/blood , Astronauts , Cytomegalovirus/isolation & purification , Space Flight , Stress, Psychological/virology , Virus Activation/physiology , Virus Shedding/physiology , Adult , Catecholamines/blood , Catecholamines/urine , Cytomegalovirus/immunology , Female , Humans , Hydrocortisone/blood , Infection Control/methods , Male , Stress, Psychological/immunology , Stress, Psychological/urine , Virus Latency
14.
Neuroimmunomodulation ; 8(2): 51-8, 2000.
Article in English | MEDLINE | ID: mdl-10965229

ABSTRACT

Herpesviruses are leading causes of infectious blindness and death in immunocompromised individuals. Impaired cellular immunity, which is known to result in increased frequency and severity of herpesvirus infections, has been demonstrated both during and after spaceflight. Therefore, we examined whether Epstein-Barr virus (EBV), a well-characterized latent herpesvirus, undergoes reactivation in astronauts. Sera from Shuttle astronauts, taken before and after spaceflight, were examined for evidence of EBV reactivation. The geometric mean antibody titer to EBV viral capsid antigen (VCA) was significantly increased prior to flight compared to baseline (p = 0. 0001). After spaceflight, evidence of acute lytic replication was found in which 8- to 64-fold increases in EBV early antigen (EA) antibodies occurred without significant increases in antibodies to measles virus. Additionally, stress-induced shifts in circulating leukocytes and elevated levels of urinary cortisol and epinephrine were found. Overall, significant increases in EA or high VCA/EA antibody titers were found in 8 of 23 (35%) male astronauts and 3 of 5 (60%) female astronauts. These results indicate that stress reactivates EBV prior to flight and suggest that acute lytic replication of EBV occurs during spaceflight.


Subject(s)
Astronauts , Epstein-Barr Virus Infections/virology , Herpesvirus 4, Human/immunology , Stress, Physiological/virology , Virus Activation , Adrenocorticotropic Hormone/blood , Adult , Antibodies, Viral/blood , Epinephrine/blood , Epstein-Barr Virus Infections/immunology , Female , Humans , Hydrocortisone/blood , Leukocyte Count , Male , Middle Aged , Neuroimmunomodulation , Neutrophils/cytology , Norepinephrine/blood , Stress, Physiological/immunology
15.
Aviat Space Environ Med ; 70(12): 1211-3, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10596777

ABSTRACT

BACKGROUND: Astronauts experience psychological and physical stresses that may result in reactivation of latent viruses during space-flight, potentially increasing the risk of disease among crewmembers. HYPOTHESIS: The shedding of Epstein-Barr virus (EBV) in the saliva of astronauts will increase during spaceflight. METHODS: A total of 534 saliva specimens were collected from 11 EBV-seropositive astronauts before, during, and after four space shuttle missions. The presence of EBV DNA in saliva, assessed by polymerase chain reaction (PCR), was used to determine shedding patterns before, during, and after space-flight. RESULTS: EBV DNA was detected more frequently before flight than during (p < 0.001) or after (p < 0.01) flight. No significant difference between the inflight and postflight periods was detected in the frequency of occurrence of EBV DNA. CONCLUSIONS: The increased frequency of shedding of EBV before flight suggests that stress levels may be greater before launch than during or after spaceflight.


Subject(s)
Astronauts , DNA, Viral/analysis , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/physiology , Saliva/virology , Space Flight , Virus Shedding/physiology , Analysis of Variance , Astronauts/psychology , Chi-Square Distribution , Female , Humans , Incidence , Infection Control , Male , Polymerase Chain Reaction/methods , Specimen Handling/methods , Stress, Physiological/immunology , Stress, Physiological/psychology , Stress, Psychological/immunology , Stress, Psychological/psychology , United States , Virus Activation/physiology , Virus Latency/physiology
16.
Neurology ; 53(6): 1292-9, 1999 Oct 12.
Article in English | MEDLINE | ID: mdl-10522887

ABSTRACT

OBJECTIVE: To evaluate the inter-rater reliability and validity of clinical diagnostic criteria for neurodegenerative dementias. BACKGROUND: Inter-rater accuracy of the diagnosis of AD has been explored, but there are few accuracy studies for progressive supranuclear palsy (PSP) and frontotemporal lobe dementia (FTD). Furthermore, there have been no simultaneous accuracy studies in a mixed sample of patients with cortical and subcortical neurodegenerative processes. METHODS: Four experienced clinicians reviewed first-visit clinical data abstracted from the records of 40 pathologically diagnosed demented subjects. They were asked to apply the NINCDS-ADRDA criteria for AD, the NINDS-SPSP clinical criteria for PSP, the Lund and Manchester criteria for FTD, and the Consensus Guidelines for the Clinical Diagnosis of Dementia with Lewy Bodies (DLB). RESULTS: The generalized K for AD was 0.73, for PSP 0.82, for FTD 0.75, and for DLB 0.37. The K pool test showed a statistically significant difference between DLB and the other disease processes, and no differences were observed among AD, FTD, and PSP. The mean sensitivity for AD was 95%, for PSP 75%, for FTD 97%, and for DLB 34%. The mean specificity for AD was 79%, for PSP 98.5%, for FTD 97%, and for DLB 94%. CONCLUSIONS: We found improved inter-rater reliability for the diagnosis of AD among clinicians compared with earlier studies. Similarly, there was a near-perfect and substantial inter-rater agreement for the diagnosis of PSP and FTD. The sensitivity for the diagnosis of AD was high, although clinicians overdiagnosed this condition. However, there was a reasonable accuracy for the diagnosis of PSP and FTD. Heterogeneity of the clinical presentation of DLB significantly affected inter-rater agreement and accuracy. The use of multiple diagnostic criteria for cortical and subcortical dementia increases the level of clinical diagnostic accuracy.


Subject(s)
Neurodegenerative Diseases/diagnosis , Aged , Female , Humans , Male , Middle Aged , Neurodegenerative Diseases/psychology , Neuropsychological Tests , Psychiatric Status Rating Scales , Reproducibility of Results
17.
J Leukoc Biol ; 65(2): 179-86, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10088600

ABSTRACT

Changes in leukocyte subpopulations and function after spaceflight have been observed but the mechanisms underlying these changes are not well defined. This study investigated the effects of short-term spaceflight (8-15 days) on circulating leukocyte subsets, stress hormones, immunoglobulin levels, and neutrophil function. At landing, a 1.5-fold increase in neutrophils was observed compared with preflight values; lymphocytes were slightly decreased, whereas the results were variable for monocytes. No significant changes were observed in plasma levels of immunoglobulins, cortisol, or adrenocorticotropic hormone. In contrast, urinary epinephrine, norepinephrine, and cortisol were significantly elevated at landing. Band neutrophils were observed in 9 of 16 astronauts. Neutrophil chemotactic assays showed a 10-fold decrease in the optimal dose response after landing. Neutrophil adhesion to endothelial cells was increased both before and after spaceflight. At landing, the expression of MAC-1 was significantly decreased while L-selectin was significantly increased. These functional alterations may be of clinical significance on long-duration space missions.


Subject(s)
Aerospace Medicine , Leukocytes/cytology , Neutrophils/physiology , Space Flight , Adrenocorticotropic Hormone/blood , Adrenocorticotropic Hormone/urine , Adult , Cell Adhesion , Chemotaxis, Leukocyte , Female , Humans , Hydrocortisone/blood , Hydrocortisone/urine , Immunoglobulins/blood , Leukocyte Count , Leukocytes/physiology , Male , Middle Aged , Monocytes/cytology , Neutrophil Activation , Time Factors
18.
J Virol Methods ; 75(1): 83-91, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9820577

ABSTRACT

A rapid and highly sensitive fluorescent in situ hybridization (FISH) assay was developed to detect Epstein Barr virus (EBV)-infected cells in peripheral blood. Multiple fluorescein-labeled antisense oligonucleotide probes were designed to hybridize to the EBER1 transcript, which is highly expressed in latently infected cells. After a rapid (30 min) hybridization, the cells were analyzed by flow cytometry. EBER1 was detected in several positive control cell lines that have variable numbers of EBV genome copies. No EBER1 was detected in two known EBV-negative cell lines. Northern blot analyses confirmed the presence and quantity of EBER1 transcripts in each cell line. This method was used to quantify the number of EBV-infected cells in peripheral blood from a patient with chronic mononucleosis. These results indicate that EBV-infected cells can be detected at the single cell level, and that this assay can be used to quantify the number of EBV-infected cells in clinical samples.


Subject(s)
Flow Cytometry/methods , Herpesvirus 4, Human/isolation & purification , In Situ Hybridization, Fluorescence/methods , Infectious Mononucleosis/virology , RNA, Viral/isolation & purification , Blotting, Northern , DNA Probes , Herpesvirus 4, Human/genetics , Humans , RNA, Viral/genetics , Sensitivity and Specificity , Tumor Cells, Cultured
19.
Dev Med Child Neurol ; 40(2): 126-9, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9489503

ABSTRACT

This study reports the case of a 16-year-old male who presented with a history of prominent psychotic symptoms and paranoid delusions which overshadowed subtle signs and symptoms of cognitive and motor dysfunction. Intensive neurobehavioral and biochemical investigations eventually led to the diagnosis of Niemann-Pick disease, type C (NPC), an autosomal recessively inherited storage disease that is associated with the accumulation of cholesterol in lysosomes and difficulties in the processing of exogenously derived cholesterol. Clues to the presence of a neurological disorder included: a history of insidiously declining academic and athletic performance which antedated the onset of psychosis; abnormalities on mental status examination, including psychomotor slowing, memory difficulties, and impairment of higher attentional functions; physical findings of subtle downgaze impairment, mild symmetrical hyperreflexia, and lower-extremity hypertonia with flexor plantar responses, marked impairment of upper-extremity rapid alternating movements, action tremor, and bilateral posturing with stress gait maneuvers. This case demonstrates the importance of careful and persistent neurodiagnostic evaluation in adolescents with psychotic presentations, particularly when cognitive and motor deterioration is suspected, and even when head CT and MRI scans are judged to be normal.


Subject(s)
Delusions/diagnosis , Delusions/etiology , Niemann-Pick Diseases/diagnosis , Niemann-Pick Diseases/psychology , Psychotic Disorders/diagnosis , Psychotic Disorders/etiology , Adolescent , Cognition Disorders/diagnosis , Cognition Disorders/etiology , Diagnosis, Differential , Humans , Male , Neuropsychological Tests , Psychomotor Disorders/diagnosis , Psychomotor Disorders/etiology
20.
J Clin Exp Neuropsychol ; 20(5): 723-37, 1998 Oct.
Article in English | MEDLINE | ID: mdl-10079047

ABSTRACT

Patients with right and left hemisphere stroke (RH, LH) and a control group (CG) were administered a structured clinical interview (SCID-R) and rating scales for anxiety and depression (Center for Epidemiologic Studies Depression Scale, Beck Anxiety Inventory, and Hamilton Depression Rating Scale). The three groups did not differ when compared for the mean level of distress on the rating scales or frequency of mood or anxiety disorder diagnosis using the SCID-R. By contrast, participants in the LH group were more likely to be classified as distressed using rating scales cutoff scores and on measures of severity when compared only to the RH group. The rating scales were sensitive to psychiatric disorders, but lacked specificity in all groups. There were significant correlations between scales suggesting the rating scales measure a common factor in the controls, while in the stroke groups associations were weaker and less likely to be significant. Together, these results suggest the need for caution in using rating scales of depression and anxiety in neurologic patients and support the notion that these scales are sensitive to distress rather than specific for identifying depressive and anxiety disorders.


Subject(s)
Anxiety/etiology , Anxiety/psychology , Cerebrovascular Disorders/complications , Cerebrovascular Disorders/psychology , Depressive Disorder/etiology , Depressive Disorder/psychology , Aged , Anxiety/epidemiology , Cognition/physiology , Depressive Disorder/epidemiology , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neuropsychological Tests , Psychiatric Status Rating Scales , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...